Assessment of diabetes screening by general practitioners in France: the EPIDIA Study

被引:15
作者
Cogneau, J
Balkau, B
Weill, A
Liard, F
Simon, D
机构
[1] Reseau EPI Qualiso, Paris, France
[2] INSERM, U258, Villejuif, France
[3] Hop Pitie, CNAMTS, F-75651 Paris, France
[4] Hop Pitie, IRMG, F-75651 Paris, France
[5] Hop Pitie, Serv Diabetol, F-75651 Paris, France
关键词
diabetes risk factors; diabetes screening; impaired fasting glucose; general practice; undiagnosed diabetes;
D O I
10.1111/j.1464-5491.2006.01877.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Aims To audit Type 2 diabetes screening in general practice in France and to determine the frequency of undiagnosed diabetes in patients at high risk, after systematic screening and diagnosis. Methods For this study, 288 general practitioners volunteered to include all consecutive non-diabetic patients aged < 65 years who had at least two risk factors for diabetes, whatever the reason for consultation. If a plasma glucose had not been recorded in the previous 12 months, a fasting plasma glucose (FPG) was performed, with a second test if FPG >= 7.0 mmol/l. Results There were 5950 patients included. The most frequent diabetes risk factors were: age >= 40 years, 92%; overweight [body mass index (BMI) >= 27 kg/m(2)], 59%; treated hypertension, 48%; treated dyslipidaemia, 37%; family history of diabetes, 24%. Of these subjects at high risk for diabetes, 88% had a FPG measurement in their medical record (75% measured during the preceding 12 months). In the 1499 patients in whom FPG was measured, diabetes was diagnosed in 40 patients (2.7% 95% CI 1.9-3.5) and 22% had impaired fasting glucose (IFG). Thus, the frequency of undiagnosed diabetes in the 5950 high-risk patients was 0.67% (0.46-0.88). Conclusions Screening for diabetes by general practitioners in France appears to be adequate and undiagnosed diabetes is rare in patients with risk factors for diabetes, at least in those consulting the general practitioners studied.
引用
收藏
页码:803 / 807
页数:5
相关论文
共 25 条
[1]
*ADA, 1999, DIABETES CARE, V28, pS5
[2]
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[3]
*AG NAT ACC EV SAN, 2003, PRINC DEP DIAB TYP 2, P1
[4]
*BIOL, ACT BIOL REMB 2001 2
[5]
CHARLES MA, 2004, MED OBESITE, P8
[6]
COSTAGLIOLA D, 1989, DIABETES METAB, V15, P51
[7]
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study [J].
de Vegt, F ;
Dekker, JM ;
Jager, A ;
Hienkens, E ;
Kostense, PJ ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2109-2113
[8]
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].
Gaede, P ;
Vedel, P ;
Larsen, N ;
Jensen, GVH ;
Parving, H ;
Pedersen, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393
[9]
A simple pragmatic system for detecting new cases of type 2 diabetes and impaired fasting glycaemia in primary care [J].
Greaves, CJ ;
Stead, JW ;
Hattersley, AT ;
Ewings, P ;
Brown, P ;
Evans, PH .
FAMILY PRACTICE, 2004, 21 (01) :57-62
[10]
CARDIOVASCULAR RISK-FACTORS IN CONFIRMED PREDIABETIC INDIVIDUALS - DOES THE CLOCK FOR CORONARY HEART-DISEASE START TICKING BEFORE THE ONSET OF CLINICAL DIABETES [J].
HAFFNER, SM ;
STERN, MP ;
HAZUDA, HP ;
MITCHELL, BD ;
PATTERSON, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (21) :2893-2898